Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Bio Rad Laboratories Inc (NYSE:BIO)

188.46
Delayed Data
As of Jan 13
 +2.05 / +1.10%
Today’s Change
122.03
Today|||52-Week Range
194.20
+3.39%
Year-to-Date
Will 2017 Be Illumina's Best Year Yet?
Jan 13 / MotleyFool.com - Paid Partner Content
Illumina Stock Upgraded: What You Need to Know
Jan 10 / MotleyFool.com - Paid Partner Content
Here's Why Illumina Is Soaring Today
Jan 10 / MotleyFool.com - Paid Partner Content
Biotech Pre-Market Movers: ILMN, NSTG, KITE
Jan 10 / TheStreet.com - Paid Partner Content

Today’s Trading

Previous close186.41
Today’s open185.88
Day’s range185.88 - 189.24
Volume124,396
Average volume (3 months)160,890
Market cap$4.6B
Dividend yield--
Data as of 01/13/2017

Growth & Valuation

Earnings growth (last year)+26.23%
Earnings growth (this year)-28.31%
Earnings growth (next 5 years)+10.00%
Revenue growth (last year)-7.15%
P/E ratio56.6
Price/Sales2.02
Price/Book2.22

Competitors

 Today’s
change
Today’s
% change
BRKRBruker Corp+0.19+0.84%
PKIPerkinElmer Inc+0.94+1.77%
QGENQiagen NV+0.02+0.07%
AXDXAccelerate Diagnosti...+0.25+1.12%
Data as of 01/13/2017

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)$1.11
Annual revenue (last year)$2.0B
Annual profit (last year)$113.1M
Net profit margin5.60%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chairman, President &
Chief Executive Officer
Norman D. Schwartz
Chief Operating Officer &
Executive Vice President
John Goetz
Corporate headquarters
Hercules, California

Forecasts


Search for Jobs